Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma
-
Davies, A. (Cancer Research UK Centre)
;
Trask, P. (Genentech Inc.) ;
Demeter, J. (Semmelweis University) ;
Florschütz, A. (Städtisches Klinikum Dessau) ;
Hänel, M. (Klinikum Chemnitz gGmbH) ;
Kinoshita, T. (Aichi Cancer Center Hospital) ;
Pettengell, R. (St George's University) ;
Quach, H. (St Vincent's Hospital (Sydney)) ;
Robinson, S. (Bristol Haematology and Oncology Centre) ;
Sadullah, S. (James Paget Hospital) ;
Sancho, Juan-Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Udvardy, M. (Medical and Health Science Centre. University of Debrecen) ;
Witzens-Harig, M. (Uniklinik Heidelberg) ;
Knapp, A. (F. Hoffmann-La Roche Ltd) ;
Liu, W. (F. Hoffmann-La Roche Ltd) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
